期刊文献+

抑制miR-21对非小细胞肺癌顺铂耐药细胞株A549/DDP增殖和凋亡的影响及可能机制探讨 被引量:1

Effects of miR-21 inhibition on A549 / DDP cisplatin resistant cell proliferation and apoptosis in non-small cell lung cancer
下载PDF
导出
摘要 目的:探讨抑制miR-21表达对非小细胞肺癌耐药细胞株A549/DDP增殖和凋亡的影响及可能的机制。方法:应用Real-time PCR技术分别检测人非小细胞肺癌细胞株A549及其耐药株A549/DDP中miR-21的表达;将miR-21抑制剂(miR-21inhibitor)ASO-21转染至A549/DDP中,下调其miR-21的表达,在不同时间点使用MTT检测细胞的增殖,流式细胞仪AnnexinFITC检测细胞凋亡;使用生物信息学和miR的预测软件预测miR-21在非小细胞肺癌中的可能靶点。结果:①miR-21在A549/DDP细胞株的表达均为A549的3倍;②A549/DDP细胞株中转染ASO-21孵育,加入顺铂后,与对照组相比,其凋亡增加,增殖能力明显降低;③生物信息学软件分析后发现miR-21在非小细胞肺癌A549有多个调节靶点,一些蛋白分子可以调节miR-21的表达,组成肿瘤细胞的调节网络而影响肺癌细胞对顺铂的敏感性。结论:抑制miR-21可以促进顺铂耐药细胞A549/DDP的凋亡增加及抑制其增殖,miR-21可能成为逆转肺癌对顺铂耐药的新靶点。 Objective:To investigate the effects of miR-21 inhibition on proliferation and apoptosis of A549/DDP cells. Methods:MiR-21 expression was examined in A549 and A549/DDP cell lines. The inhibitor of miR-21(ASO-21) was transfected into A549/DDP. MTT and flow cytometry were performed to analyze the proliferation and apoptosis after transfection,respectively. Computational software and miR predicting database were used to predict the downstream effectors of miR-21 in the lung cancer cell line. Results:①miR-21 expression was approximately 3 times higher in A549/DDP compared with A549 cells. ②Apoptosis was induced and proliferation was suppressed in A549/DDP cells when miR-21 was inhibited. ③Computational softwares showed that multiple genes are possible downstream targets of miR-21. Some proteins could possibly regulate miR-21. Those genes form a regulating network via miR-21,resulting in regulating cisplatin chemoresistance. Conclusion:MiR-21 inhibition leads to apoptosis and proliferation suppression of A549/DDP cells, and it may be a therapeutic target to reverse cisplatin resistance in lung cancer treatment.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第5期543-547,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金面上项目资助(81370161)
关键词 肺癌 化疗 顺铂 耐药 MIR-21 lung cancer chemotherapy cisplatin chemoresistance miR-21
  • 相关文献

参考文献2

二级参考文献45

  • 1Chen C Z, Li L, Lodish H F, et al. MiRNA modulate hemato poietic lineage differentiation[J]. Science,2004, 303(5654): 83- 86.
  • 2Bartel D P. MiRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281- 297.
  • 3Blower P E, Chung J H, Verduai J S, et al. MiRNAs modulate the chemosensitivity of tumor cells[J]. Mol Cancer Ther, 2008, 7(1) :1-9.
  • 4Pascal S,Charles D. Chemoresistance in non small cell lung cancer[J]. Curr MedChem, 2005, 5(1):73-88.
  • 5Stewart D J. Mechanisms of resistance to cisplatin and carboplatin[J]. Crit RevOncol Hematol, 2007,63(1):12- 31.
  • 6H Zhu, H Wu, X P Liu, et al. Role of MiRNA miR 27a and miR-451 in the regulation of MDR1/P glycoprotein expression in human cancer cells[J]. Biochemical Pharmacology, 2008, 76 (5) : 582-588.
  • 7Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells[J]. Int J Cancer, 2008, 123(2): 372-379.
  • 8Kovalchuk O, Filkowski J, Meservv J, et al. Involvement of miR NA-451 in resistance of the MCF7 breast cancer ceils to chemothera peutic drug doxorubicin[J]. Mol Cancer Ther, 2008, 7 (7):2152- 2159.
  • 9Meng F, Henson R, Lang M, et al. Involvement of human mi RNA in growth and response to chemotherapy in human cholan giocarcinoma cell lines[J]. Gastroenterology, 2006, 130 (7):2113-2129.
  • 10Chan J A, Krichevsky A M, Kosik K S. MiRNA-21 is an anti apoptotic factor in human glioblastoma cells[J]. Cancer Res, 2005, 65(14):6029- 6033.

共引文献43

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部